OBIO
NASDAQOrchestra BioMed Holdings Inc.
Price$3.67+0.01 (+0.41%)
01:30 PM07:45 PM
News · 26 weeks56+22%
2026-01-182026-07-12
Mix3690d
- Insider18(50%)
- Other10(28%)
- SEC Filings7(19%)
- Market1(3%)
Latest news
25 items- INSIDEROfficer Sherman Darren sold $64,050 worth of shares (15,000 units at $4.27) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 1,169,327 units (SEC Form 4)4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
- SECSEC Form 144 filed by Orchestra BioMed Holdings Inc.144 - Orchestra BioMed Holdings, Inc. (0001814114) (Subject)
- PROrchestra BioMed Joins Russell 3000® and Russell 2000® IndexesNEW HOPE, Pa., June 29, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) ("Orchestra BioMed" or the "Company"), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, announced today that it has joined the broad-market Russell 3000® Index and the small-cap Russell 2000® Index at the conclusion of the 2026 Russell indexes reconstitution, effective after the U.S. market close on June 26, 2026. The Russell indexes reconstitution captures the 4,000 largest U.S. stocks as of April 30, ranking them by total market capitalization. Membership in the U.S. all-cap Russell 3000® Index, which remains in place until the ne
- INSIDERDirector Fain Eric S was granted 17,327 shares and covered exercise/tax liability with 4,261 shares (SEC Form 4) to satisfy tax liability4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
- INSIDERDirector Pacitti David was granted 17,327 shares and covered exercise/tax liability with 3,784 shares, increasing direct ownership by 30% to 58,511 units (SEC Form 4) (for tax liability)4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
- INSIDERDirector Cleary Chris covered exercise/tax liability with 3,510 shares, decreasing direct ownership by 10% to 33,391 units (SEC Form 4) to cover withholding tax4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
- INSIDERDirector Connealy Pamela Ann was granted 17,327 shares, increasing direct ownership by 36% to 66,038 units (SEC Form 4)4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
- INSIDERSEC Form 4 filed by Director Aryeh Jason4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
- INSIDERDirector Mack John Prosper was granted 34,653 shares and covered exercise/tax liability with 3,510 shares, increasing direct ownership by 77% to 71,429 units (SEC Form 4) to satisfy withholding obligation4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
- SECOrchestra BioMed Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Orchestra BioMed Holdings, Inc. (0001814114) (Filer)
- SECSEC Form S-8 filed by Orchestra BioMed Holdings Inc.S-8 - Orchestra BioMed Holdings, Inc. (0001814114) (Filer)
- NEWSSidoti Events, LLC's June Small-Cap Virtual ConferenceNEW YORK, NY / ACCESS Newswire / June 16, 2026 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day June Small-Cap Virtual Investor Conference taking place Wednesday and Thursday, June 17-18, 2026. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links.Presentation Schedule*All Times EDTWednesday, June 17, 2026 (Day 1)8:30-9:00Avalon Advanced Materials (AVL)Aurora Mobile (JG)9:15-9:45Onity Group (ONIT)*****10:00-10:30Charles River Associates (CRAI)*****10:45-11:15RLJ Lodging Trust (RLJ)*****11:30-12:00GigaCloud Technology (GCT)Cibus (CBUS)12:1
- INSIDERChief Financial Officer Taylor Andrew Lawrence covered exercise/tax liability with 36,352 shares, decreasing direct ownership by 6% to 593,065 units (SEC Form 4) to satisfy tax liability4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
- INSIDEROfficer Hochman David P covered exercise/tax liability with 6,566 shares, decreasing direct ownership by 0.31% to 1,060,746 units (SEC Form 4) (tax withholding)4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
- INSIDEROfficer Hochman David P bought $19,150 worth of shares (5,000 units at $3.83), increasing direct ownership by 0.47% to 1,064,029 units (SEC Form 4)4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
- INSIDEROfficer Sherman Darren sold $58,050 worth of shares (15,000 units at $3.87) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 1,184,327 units (SEC Form 4)4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
- PROrchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NEW HOPE, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) ("Orchestra BioMed" or the "Company"), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with market-leading global medical device companies, reported today that, on June 1, 2026, the Compensation Committee of the Orchestra BioMed Board of Directors granted stock options to purchase an aggregate of 85,500 shares of the Company's common stock to five newly hired employees. The awards were granted pursuant to the Orchestra Biomed Holdings, Inc. 2025 New Hire Inducement Plan as an inducement material to each new employee entering employment with Or
- SECSEC Form 144 filed by Orchestra BioMed Holdings Inc.144 - Orchestra BioMed Holdings, Inc. (0001814114) (Subject)
- INSIDERChief Financial Officer Taylor Andrew Lawrence covered exercise/tax liability with 3,076 shares, decreasing direct ownership by 0.49% to 629,417 units (SEC Form 4) (for tax liability)4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
- INSIDEROfficer Sherman Darren covered exercise/tax liability with 4,925 shares, decreasing direct ownership by 0.41% to 1,199,327 units (SEC Form 4) to satisfy tax liability4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
- INSIDERDirector Aryeh Jason bought $2,494 worth of shares (665 units at $3.75), increasing direct ownership by 0.57% to 118,118 units (SEC Form 4)4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
- PROrchestra BioMed to Participate in the Jefferies Global Healthcare ConferenceNEW HOPE, Pa., May 19, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO, "Orchestra BioMed" or the "Company")), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced that company management will be participating in the Jefferies Global Healthcare Conference. Chairman and CEO David Hochman will participate in a fireside chat with Matt Taylor, Managing Director at Jefferies at 9:55am ET on Thursday June 4, 2026 and will also host one-on-one meetings with investors that day and on Wednesday, June 3. The fireside chat will be accessible to investors and interested parties via a live webcast, which
- INSIDEROfficer Hochman David P bought $18,850 worth of shares (5,000 units at $3.77), increasing direct ownership by 0.47% to 1,059,029 units (SEC Form 4)4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
- INSIDERDirector Aryeh Jason bought $34,987 worth of shares (8,971 units at $3.90), increasing direct ownership by 8% to 117,453 units (SEC Form 4)4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
- INSIDERDirector Fain Eric S bought $82,600 worth of shares (20,000 units at $4.13) (SEC Form 4)4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
OBIO FAQ
6 questionsWhere does OBIO stock trade?
Orchestra BioMed Holdings Inc. (OBIO) is listed on NASDAQ.What sector and industry is OBIO in?
Orchestra BioMed Holdings Inc. operates in the Health Care sector, Medicinal Chemicals and Botanical Products industry.When did Orchestra BioMed Holdings Inc. go public?
Orchestra BioMed Holdings Inc. (OBIO) completed its IPO in 2020.What are analysts saying about OBIO?
Orchestra BioMed Holdings Inc. has had 8 recent analyst actions on file. The most recent action was from TD Cowen: Buy with a $1500.00 price target on 2025-12-10. Recent price targets range from $1200.00 to $1600.00.What companies are similar to OBIO?
Notable peers in the same industry include PM (Philip Morris International Inc), BTI (British American Tobacco Industries p.l.c.), MO (Altria Group Inc.), DFTX (Definium Therapeutics Inc.), RLX (RLX Technology Inc.). Compare OBIO side-by-side with any of them on Quantisnow.How can I track OBIO on Quantisnow?
Quantisnow aggregates Orchestra BioMed Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow OBIO to receive live email and push alerts on every new disclosure.